Partnership between Switzerland and Israel to improve genetics

Israeli and Swiss companies team up to improve cannabis genetics, new strains expected

A Swiss cannabis company has partnered with an Israeli genome analysis company to create better genetics for new strains of cannabis. Ness Ziona, Israel-based gene sequencing company NRGene announced the collaboration with Pure Cannabis Research AG of Zug, Switzerland.

New original strains

The non-exclusive partnership between the two companies "will facilitate faster development of cannabis varieties than the current industry standard," the statement said. As part of this partnership, Pure Cannabis Research plans to produce cannabis strains tailored to the needs of its customers. Researchers will focus on creating strains of cannabis. According to them, they will be healthier and more robust. And therefore, optimized for commercial production.

Switzerland, Israel, genetics

The new varieties will have customized profiles of cannabinoids, terpenes and flavonoids targeted for specific therapeutic uses. Strains that provide unique flavor profiles for energy drinks and products that offer alternative to tobacco will also be developed.

to read :  Ruderalis, wild hemp

Stevens Senn, CEO of Pure Holding Group, (parent company of Pure Cannabis), said the partnership will help his company identify the desirable genetic traits for cannabis. As a result, they will be able to create new strains that optimize the expression of these characters. New cannabis varieties will then be used in the product line cannabidiol of the society.

“We are at the forefront of CBD products for alternatives to tobacco, beverages, cosmetics and other uses in the Swiss and European markets,” said Senn.

Senn noted that NRGene has already mapped the genomes of several plants, including wheat, potato, barley, oats, and strawberry crops that have a genome bigger or more complex than man.

"NRGene has refined the process of identifying key genetic traits for virtually all plant species. We have therefore joined them in supporting our selection program. We are going to develop plants with all the biologically possible traits to better serve the markets in new varieties, "said Senn.

Cannabis genomes to map

Switzerland, Israel, genetics

The research conducted by the new partnership will include mapping the genomes of several cannabis strains. The data collected will then be used to develop a pangenoma of cannabis. This represents the set of genes of all varieties of a species ...

“This complex project will create a collection of sequences that will provide unique and essential information about the natural genetic diversity of cannabis,” according to NRGene.

Gil Ronen, CEO of NRGene, said collaboration with Pure Cannabis Research will help to better understand the potential uses of all forms of cannabis.

“Recognition of the importance of cannabis in certain products and in hemp in general is increasing globally. Whether for a multitude of medical issues or as a high-value renewable resource with many ecological uses ”. Says Dr Ronen. “Cannabis is increasingly recognized as the most viable solution for many health problems. And we are happy to be able to contribute to the well-being of people. "

To read :

The genome of cannabis

to read :  Marijuana: Effectiveness against Asthma

Native tobacco to quit, and cannabis without THC

New molecular targets interact with CBD

Find the right strain for your DNA

Tags : GeneticIsraelSearch

The author Weed-master

Weed media broadcaster and communications manager specializing in legal cannabis. Do you know what they say? knowledge is power. Understand the science behind cannabis medicine, while staying up to date with the latest health related research, treatments and products. Stay up to date with the latest news and ideas on legalization, laws, political movements. Discover tips, tricks and how-to guides from the most seasoned growers on the planet as well as the latest research and findings from the scientific community on the medical qualities of cannabis.